These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2495219)
81. Impact of immediate acidification of blood on measurement of plasma tissue plasminogen activator (tPA) activity in surgical patients. Nilsson TK; Mellbring G Clin Chem; 1989 Sep; 35(9):1999. PubMed ID: 2505950 [No Abstract] [Full Text] [Related]
82. Lack of an association between connexin-37, stromelysin-1, plasminogen activator-inhibitor type 1 and lymphotoxin-alpha genes and acute coronary syndrome in Czech Caucasians. Hubacek JA; Staněk V; Gebauerová M; Pilipčincová A; Poledne R; Aschermann M; Skalická H; Matoušková J; Kruger A; Pěnička M; Hrabáková H; Veselka J; Hájek P; Lánská V; Adámková V; Pit'ha J Exp Clin Cardiol; 2010; 15(3):e52-6. PubMed ID: 20959880 [TBL] [Abstract][Full Text] [Related]
83. Short-time centrifugation at high centrifugal forces in plasma preparation for tPA activity determination. Hertfelder HJ; Popov-Cenic S Thromb Res; 1990 Jul; 59(2):417-20. PubMed ID: 2122544 [No Abstract] [Full Text] [Related]
84. Plasminogen Activator Inhibitor-1: Another String in the Platelet-Derived Extracellular Vesicles Bow? Arangalage D; Franck G; Caligiuri G JACC Basic Transl Sci; 2022 Oct; 7(10):998-1000. PubMed ID: 36337917 [TBL] [Abstract][Full Text] [Related]
85. Plasminogen and fibrinogen plasma levels in coronary artery disease. Kazmi RS; Lwaleed BA Rev Bras Hematol Hemoter; 2012; 34(4):262-3. PubMed ID: 23047269 [No Abstract] [Full Text] [Related]
86. Chemical Adjustment of Fibrinolysis. Shibeko AM; Ilin IS; Podoplelova NA; Sulimov VB; Panteleev MA Pharmaceuticals (Basel); 2024 Jan; 17(1):. PubMed ID: 38256925 [TBL] [Abstract][Full Text] [Related]
87. Prognostic role of tissue plasminogen activator in coronary artery disease with or without aortic valve sclerosis. Lin B; Shen Y; Zhang P; Shen Y; Gu Y; He X; Li J; Yang K; Shen W; Zhang Q; Xin Y; Liu Y ESC Heart Fail; 2023 Aug; 10(4):2541-2549. PubMed ID: 37308095 [TBL] [Abstract][Full Text] [Related]
88. Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease. Mayyas F; Bani Omar E Heliyon; 2022 Jul; 8(7):e09836. PubMed ID: 35815138 [TBL] [Abstract][Full Text] [Related]
89. Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity. Lalić K; Jotić A; Rajković N; Singh S; Stošić L; Popović L; Lukić L; Miličić T; Seferović JP; Maćešić M; Stanarčić J; Čivčić M; Kadić I; Lalić NM Int J Endocrinol; 2015; 2015():390185. PubMed ID: 26089884 [TBL] [Abstract][Full Text] [Related]